文献速递肥胖与代谢综合征

高剂量DHA对LDL相关特征的影响比高剂量EPA更显著:ComparED研究

High-Dose DHA Has More Profound Effects on LDL-Related Features Than High-Dose EPA: The ComparED Study.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

在48名男性和106名腹型肥胖伴亚临床炎症的受试者中开展双盲对照交叉试验,比较2.7 g/d EPA、2.7 g/d DHA与3 g/d玉米油。与EPA相比,DHA使LDL-C升高3.3%、平均LDL颗粒增大0.7 Å、小LDL比例降低3.2%。

要点

  • 与EPA相比,DHA使LDL-C升高3.3%(P=0.038)。
  • DHA较EPA使平均LDL颗粒增大0.7 Å(P<0.001)、小LDL比例降低3.2%(P<0.01)。
  • DHA较EPA增加LDL apoB100分解代谢率11.4%和生成率9.4%。

核心结论

  • 高剂量DHA补充较EPA增加LDL周转并使LDL颗粒增大。

研究设计与样本

  • 双盲、对照、交叉研究,纳入48名男性和106名女性腹型肥胖伴亚临床炎症受试者。
  • 随机接受三个10周治疗阶段:2.7 g/d EPA、2.7 g/d DHA、3 g/d玉米油,各阶段间隔9周洗脱。
  • 在部分受试者(n=19)中用氘代亮氨酸恒速输注评估含apoB100脂蛋白的体内动力学。

主要发现

  • 与EPA相比,DHA使LDL-C升高3.3%(P=0.038)。
  • 与EPA相比,DHA使平均LDL颗粒增大0.7 Å(P<0.001)、小LDL比例降低3.2%(P<0.01)。
  • EPA和DHA均降低PCSK9浓度且降幅相似(EPA -18.2% vs DHA -25.0%;P<0.0001 vs 对照)。
  • 与EPA相比,DHA使LDL apoB100分解代谢率增加11.4%(P=0.008)、生成率增加9.4%(P=0.03)。

关键数值与推荐

  • EPA剂量2.7 g/d、DHA剂量2.7 g/d、玉米油3 g/d,均以三个1 g胶囊每日共3 g形式提供。

临床怎么用

  • 原文未给出临床实践建议。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Supplementation with high-dose docosahexaenoic acid (DHA) increases serum low-density lipoprotein (LDL) cholesterol (LDL-C) concentrations more than high-dose eicosapentaenoic acid (EPA). The mechanisms underlying this difference are unknown. OBJECTIVE: To examine the phenotypic change in LDL and mechanisms responsible for the differential LDL-C response to EPA and DHA supplementation in men and women at risk of cardiovascular disease. DESIGN, SETTING, PARTICIPANTS, AND INTERVENTION: In a double-blind, controlled, crossover study, 48 men and 106 women with abdominal obesity and subclinical inflammation were randomized to a sequence of three treatment phases: phase 1, 2.7 g/d of EPA; phase 2, 2.7 g/d of DHA; and phase 3, 3 g/d of corn oil. All supplements were provided as three 1-g capsules for a total of 3 g/d. The 10-week treatment phases were separated by a 9-week washout period. MAIN OUTCOME MEASURE: In vivo kinetics of apolipoprotein (apo)B100-containing lipoproteins were assessed using primed-constant infusion of deuterated leucine at the end of each treatment in a subset of participants (n = 19). RESULTS: Compared with EPA, DHA increased LDL-C concentrations (+3.3%; P = 0.038) and mean LDL particle size (+0.7 Å; P < 0.001) and reduced the proportion of small LDL (-3.2%; P < 0.01). Both EPA and DHA decreased proprotein convertase subtilisin/kexin type 9 concentrations similarly (-18.2% vs -25.0%; P < 0.0001 vs control). Compared with EPA, DHA supplementation increased both the LDL apoB100 fractional catabolic rate (+11.4%; P = 0.008) and the production rate (+9.4%; P = 0.03). CONCLUSIONS: The results of the present study have shown that supplementation with high-dose DHA increases LDL turnover and contributes to larger LDL particles compared with EPA.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Allaire J, Vors C, Tremblay AJ, et al. High-Dose DHA Has More Profound Effects on LDL-Related Features Than High-Dose EPA: The ComparED Study. J Clin Endocrinol Metab. 2018. PMID: 29846653. doi:10.1210/jc.2017-02745

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。